by Elena Iemma | Apr 3, 2024 | Events
Thank you to everyone who participated in the 16th annual Westin Immunogenicity Seminar! The day would not have been a success without you. Check out these photos from the event. A special thank you to the event’s organizing committee: Prof. Keishi Fujio, M.D.,...
by Elena Iemma | Mar 29, 2024 | News
PROVIDENCE, RI, April 1, 2024 /PRNewswire/ — Read the publication. In the pursuit of developing novel biologic entities, scientists harnessing the power of AI and generative biology depend on computational tools for predicting and managing immunogenicity risk –...
by Elena Iemma | Mar 5, 2024 | Events
June 13 & 14, 2024 9:00am – 5:00pm (with receptions to follow!) 350 Eddy St. Providence, RI 02903 Registration is closed The Artificial Intelligence / Human Intelligence & Immunoinformatics Workshop will take place on June 13 and 14th at the South Street...
by Elena Iemma | Feb 23, 2024 | News
If you missed the posters that we presented at AAPS NBC 2024, don’t worry! Click each poster below to enlarge it or download. Have questions or interested in discussing these studies more? Send us a message here. An “I” (Immunogenicity Risk...
by Elena Iemma | Dec 20, 2023 | News
PROVIDENCE, RI, December 20, 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”), an internationally recognized leader in the field of immunogenicity, today announced that Eisai Co. Ltd. (“Eisai”) has licensed EpiVax’s ISPRI toolkit for immunogenicity risk assessment of...
